The objective of the present study was to evaluate the feasibility and toxicity of a
preoperative alternating chemotherapy and radiotherapy program followed by surgery in …

Preoperative chemotherapy has become an accepted treatment for stage IIIA (N2) non–
small-cell lung cancer (NSCLC). The majority of induction regimens employ cisplatin …

A group of 70 patients with locally advanced non-small-cell lung cancer (LA-NSCLC),
treated in different phase II–III trials with platinum-based chemotherapy in two institutions …

Two controversies regarding the role of induction therapy before surgery in non-small-cell
lung cancer are considered through a review of the literature and ongoing trials worldwide …

Background Combined-modality therapy has become standard for many patients with non-
small cell lung cancer. Although surgical resection offers the best chance for long-term …

Hintergrund: Die Mediastinoskopie hat eine hohe Sensitivität für das Lymphknotenstaging
und eine Spezifität von 100%. Der Nachteil der Invasivität ist damit gegenüber …

Surgery plays a vital role in the management of Stages I-IIIa NSCLC. Careful patient
selection and improved perioperative care now allow pulmonary resection to be performed …

Because the majority of patients with stage IIIA N2 nonâ small-cell lung cancer (NSCLC)
ultimately die of distant metastases, recent efforts to improve their intermediate-and long …

Die Frage nach dem Einfluß der lokoregionären Tumorkontrolle auf das Gesamtüberleben
von Patienten mit soliden Tumoren wird auch weiterhin kontrovers diskutiert. Dabei spielen …

Die Induktions-Chemotherapie und die Induktions-Chemo-Radiotherapie dokumentierten in
vielen Phase-II-Studien ihre Effektivität und Verträglichkeit und bewiesen in einigen Phase …